text
"['\n4. 매출 및 수주상황\n가. 매출실적 ( 내부거래 제거전 현황임. \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 단, 제일약품 매출 현황은 연결 매출액 기준으로 작성)\n(단위 :천원 \xa0)\n사업부문\n매출유형\n품 목\n\xa0제64기분기\n\xa0제63기연간\n\xa0제62기연간\n의약품제조\n제품\n케펜텍\n수출\n7,841,617\n11,171,437\n8,673,228\n내수\n4,460,971\n5,557,305\n7,081,553\n합계\n12,302,588\n16,728,742\n15,754,781\n쿨파프\n수출\n1,292,725\n2,703,966\n-\n내수\n1,280,072\n511,847\n2,003,977\n합계\n2,572,797\n3,215,813\n2,003,977\n티에스원\n내수\n3,585,905\n4,837,090\n5,454,509\n넥실렌\n내수\n7,015,117\n8,119,548\n10,197,180\n크라비트\n수출\n183,116\n210,641\n183,682\n내수\n4,415,220\n5,031,389\n4,321,967\n합계\n4,598,336\n5,242,030\n4,505,649\n베라실\n내수\n5,753,654\n6,210,710\n5,817,961\n란스톤캡슐\n내수\n5,340,350\n7,501,507\n6,650,092\n스타브론\n내수\n3,846,303\n5,079,411\n5,968,898\n비유피-4\n내수\n5,042,981\n5,448,142\n6,245,158\n옴니세프\n내수\n2,431,194\n3,568,810\n3,523,816\n리피토플러스\n내수\n12,025,088\n7,510,322\n3,359,900\n기타\n수출\n15,661,294\n23,049,246\n21,779,785\n내수\n56,807,197\n74,867,509\n66,658,182\n합계\n72,468,491\n97,916,755\n88,437,967\n소계\n수출\n24,978,752\n37,135,290\n30,636,695\n내수\n112,004,052\n134,243,590\n127,283,193\n합계\n136,982,804\n171,378,880\n157,919,888\n상품\n리피토\n내수\n131,562,209\n182,910,705\n176,606,941\n리리카\n내수\n57,818,387\n72,077,548\n66,982,277\n쎄레브렉스\n내수\n36,937,483\n47,876,800\n47,318,842\n란스톤엘에프디티\n내수\n17,376,981\n24,629,539\n29,921,078\n뉴론틴\n내수\n18,417,550\n23,976,814\n23,741,407\n카듀엣\n내수\n13,729,521\n18,487,639\n18,484,886\n덱실란트 디알 캡슐\n내수\n14,798,837\n20,973,859\n17,528,588\n진정주비타\n내수\n1,065,247\n3,320,756\n1,175,581\n투엑스비 듀얼\n내수\n2,158,817\n3,481,568\n3,104,482\n한방파프수\n내수\n1,879,033\n3,340,254\n2,934,782\n록펜텍\n내수\n1,662,850\n1,387,109\n1,309,579\n기타\n수출\n652,116\n24,471,452\n364,948\n내수\n139,001,126\n185,867,369\n205,208,579\n합계\n139,653,242\n210,338,821\n205,573,527\n소계\n수출\n652,116\n24,471,452\n364,948\n내수\n436,408,041\n588,329,960\n594,317,022\n합계\n437,060,157\n612,801,412\n594,681,970\n기타\n수탁매출외\n내수\n22,210,817\n5,605,600\n3,725,307\n지주사외\n기타\n경영자문\n내수\n2,982,114\n3,832,254\n3,660,158\n임대료\n내수\n3,723,485\n4,874,296\n4,929,904\n지분법수익\n내수\n3,368,182\n2,907,054\n3,328,312\n판매대행\n내수\n19,393,516\n23,495,232\n23,211,328\n합 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0계\n수출\n25,630,868\n61,606,742\n31,001,643\n내수\n600,090,207\n763,287,986\n760,455,224\n합계\n625,721,075\n824,894,728\n791,456,867\n나. 판매경로 및 판매방법 등\n(1) 판매경로\n\xa0[제일약품] \xa0 \xa0 원외 \xa0 \xa0 \xa0 : \xa0 84.9% \xa0 \xa0 \xa0 종합병원 : \xa0 \xa09.1% \xa0 \xa0 \xa0 \xa0 \xa0관계사 \xa0 \xa0: \xa0 \xa0 0.6%  \xa0 \xa0 기타 \xa0 \xa0 \xa0 : \xa0 \xa02.6% \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0 \xa0 : \xa0 \xa02.8% [제일헬스사이언스] \xa0 약국 \xa0 \xa0: \xa0 59.0% \xa0 \xa0 \xa0 \xa0 \xa0 도매 \xa0 \xa0: \xa0 \xa08.7% \xa0 \xa0 \xa0 \xa0 \xa0특판 \xa0 \xa0: \xa0 \xa05.1%  \xa0기타 \xa0 \xa0: \xa0 \xa0 7.6% \xa0 \xa0 \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0: \xa0 \xa019.6%\n(2) 판매방법 및 조건\n\xa0 방법 : 주문판매 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0조건 : 외상매출후 현금, 어음, 카드등 수금\n(3) 판매전략\n\xa0 \xa0 \xa01. Product Specialist 제도 운영으로 마케팅력의 극대화 \xa0 \xa0 2. 학술세미나, 제품설명회의 확대로 고객만족 마케팅 전개 \xa0 \xa0 3. 정도의 영업지향 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa04. 제품별 시장 차별화 전략\n']"
